Zynerba Press Releases

11 Oct 23 HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINE

4 Oct 23 Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions

29 Sep 23 Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023

14 Sep 23 Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium

14 Aug 23 HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.

8 Aug 23 Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting

25 Jul 23 Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting

28 Jun 23 Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting

20 Jun 23 Zynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference

13 Jun 23 Zynerba Pharmaceuticals Announces Partial Adjournment of Annual Meeting